controlled substances prescription monitoring program

Updated recordkeeping requirements to allow electronic systems to replace the physical red 'C' stamp for controlled substance prescriptions, streamlining pharmacy operations.

Added new exceptions allowing faxed prescriptions for compounded medications, long-term care residents, and hospice patients, expanding flexibility for specific care scenarios.

Created a new exemption for medication-assisted treatment for substance use disorders, removing the mandatory electronic prescribing requirement for these specific cases.

Adjusted reporting requirements to distinguish between the date a prescription is dispensed versus the date it is sold to the ultimate user, effective July 1, 2027.

Added specific exemptions from patient utilization report requirements for patients receiving hospice care, cancer treatment, dialysis, or acute pain management for short procedures.

Changed the deadline for electronic medical record integration from an unspecified date to December 31, 2026, providing a clear compliance target for vendors.